Leap Therapeutics Inc (LPTX) - Financial and Strategic SWOT Analysis Review
![](/report_cover/1896/leap-therapeutics-inc-lptx-financial-n-strategic-swot-analysis-review_en.gif)
Leap Therapeutics Inc (LPTX) Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Leap Therapeutics Inc (Leap Therapeutics) is a clinical-stage biopharmaceutical company that develops novel therapeutics to treat patients with cancer. The company’s pipeline products include DKN-01and TRX518. DKN-1 is a monoclonal antibody that targets the Dickkopf-1 (DKK-1) protein, intended for the treatment of gastroesophageal cancer, hepatobiliary cancer, prostate cancer and gynecologic cancer. TRX518 is a humanized anti-GITR (glucocorticoid-induced tumor necrosis factor receptor) monoclonal antibody that enhances the immune system’s anti-tumor response and is intended for the treatment of solid tumors. Leap Therapeutics is headquartered in Cambridge, Massachusetts, the US.
Leap Therapeutics Inc Key Recent Developments
May 14,2021: Leap Therapeutics Reports First Quarter 2021 Financial Results
Feb 22,2021: Leap Therapeutics to Present at Upcoming Virtual Investor Conferences
Aug 24,2020: Leap Therapeutics expands leadership team with addition of two industry veterans
Aug 13,2020: Leap Therapeutics reports second quarter 2020 financial results
May 14,2020: Leap Therapeutics reports first quarter 2020 financial results
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Leap Therapeutics Inc (Leap Therapeutics) is a clinical-stage biopharmaceutical company that develops novel therapeutics to treat patients with cancer. The company’s pipeline products include DKN-01and TRX518. DKN-1 is a monoclonal antibody that targets the Dickkopf-1 (DKK-1) protein, intended for the treatment of gastroesophageal cancer, hepatobiliary cancer, prostate cancer and gynecologic cancer. TRX518 is a humanized anti-GITR (glucocorticoid-induced tumor necrosis factor receptor) monoclonal antibody that enhances the immune system’s anti-tumor response and is intended for the treatment of solid tumors. Leap Therapeutics is headquartered in Cambridge, Massachusetts, the US.
Leap Therapeutics Inc Key Recent Developments
May 14,2021: Leap Therapeutics Reports First Quarter 2021 Financial Results
Feb 22,2021: Leap Therapeutics to Present at Upcoming Virtual Investor Conferences
Aug 24,2020: Leap Therapeutics expands leadership team with addition of two industry veterans
Aug 13,2020: Leap Therapeutics reports second quarter 2020 financial results
May 14,2020: Leap Therapeutics reports first quarter 2020 financial results
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
Leap Therapeutics Inc - Key Facts
Leap Therapeutics Inc - Key Employees
Leap Therapeutics Inc - Key Employee Biographies
Leap Therapeutics Inc - Major Products and Services
Leap Therapeutics Inc - History
Leap Therapeutics Inc - Company Statement
Leap Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Leap Therapeutics Inc - Business Description
Business Segment: License Revenue
Performance
R&D Overview
Leap Therapeutics Inc - Corporate Strategy
Leap Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Leap Therapeutics Inc - Strengths
Leap Therapeutics Inc - Weaknesses
Leap Therapeutics Inc - Opportunities
Leap Therapeutics Inc - Threats
Leap Therapeutics Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Leap Therapeutics Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
May 14, 2021: Leap Therapeutics Reports First Quarter 2021 Financial Results
Feb 22, 2021: Leap Therapeutics to Present at Upcoming Virtual Investor Conferences
Aug 24, 2020: Leap Therapeutics expands leadership team with addition of two industry veterans
Aug 13, 2020: Leap Therapeutics reports second quarter 2020 financial results
May 14, 2020: Leap Therapeutics reports first quarter 2020 financial results
Mar 16, 2020: Leap Therapeutics reports fourth quarter and full year 2019 financial results
Jan 06, 2020: BeiGene obtains certain rights for Leap Therapeutics’ cancer drug
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Leap Therapeutics Inc - Key Facts
Leap Therapeutics Inc - Key Employees
Leap Therapeutics Inc - Key Employee Biographies
Leap Therapeutics Inc - Major Products and Services
Leap Therapeutics Inc - History
Leap Therapeutics Inc - Company Statement
Leap Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Leap Therapeutics Inc - Business Description
Business Segment: License Revenue
Performance
R&D Overview
Leap Therapeutics Inc - Corporate Strategy
Leap Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Leap Therapeutics Inc - Strengths
Leap Therapeutics Inc - Weaknesses
Leap Therapeutics Inc - Opportunities
Leap Therapeutics Inc - Threats
Leap Therapeutics Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Leap Therapeutics Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
May 14, 2021: Leap Therapeutics Reports First Quarter 2021 Financial Results
Feb 22, 2021: Leap Therapeutics to Present at Upcoming Virtual Investor Conferences
Aug 24, 2020: Leap Therapeutics expands leadership team with addition of two industry veterans
Aug 13, 2020: Leap Therapeutics reports second quarter 2020 financial results
May 14, 2020: Leap Therapeutics reports first quarter 2020 financial results
Mar 16, 2020: Leap Therapeutics reports fourth quarter and full year 2019 financial results
Jan 06, 2020: BeiGene obtains certain rights for Leap Therapeutics’ cancer drug
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Leap Therapeutics Inc, Key Facts
Leap Therapeutics Inc, Key Employees
Leap Therapeutics Inc, Key Employee Biographies
Leap Therapeutics Inc, Major Products and Services
Leap Therapeutics Inc, History
Leap Therapeutics Inc, Subsidiaries
Leap Therapeutics Inc, Key Competitors
Leap Therapeutics Inc, Ratios based on current share price
Leap Therapeutics Inc, Annual Ratios
Leap Therapeutics Inc, Annual Ratios (Cont...1)
Leap Therapeutics Inc, Interim Ratios
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Leap Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Leap Therapeutics Inc, Key Facts
Leap Therapeutics Inc, Key Employees
Leap Therapeutics Inc, Key Employee Biographies
Leap Therapeutics Inc, Major Products and Services
Leap Therapeutics Inc, History
Leap Therapeutics Inc, Subsidiaries
Leap Therapeutics Inc, Key Competitors
Leap Therapeutics Inc, Ratios based on current share price
Leap Therapeutics Inc, Annual Ratios
Leap Therapeutics Inc, Annual Ratios (Cont...1)
Leap Therapeutics Inc, Interim Ratios
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Leap Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Leap Therapeutics Inc, Performance Chart (2016 - 2020)
Leap Therapeutics Inc, Ratio Charts
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021
Leap Therapeutics Inc, Performance Chart (2016 - 2020)
Leap Therapeutics Inc, Ratio Charts
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021